| |
| |
|
| Insider
Information: |
Zulueta Alfonso G |
| Relationship: |
Director |
| City: |
Indianapolis |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
228,617 |
|
|
Indirect Shares
|
4,667 |
|
|
| Direct
Value |
$50,369,133 |
|
|
|
Indirect Value
|
$3,966,903 |
|
|
| Total
Shares |
233,284 |
|
|
| Total
Value |
$54,336,036 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
5
|
0
|
|
Stock
price went up :
|
5
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
5.0
|
0.0
|
| Percentage
Gain/Loss : |
 35.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eli Lilly & Co |
LLY |
SVP & President, Lilly... |
2021-02-08 |
56,947 |
2021-02-08 |
4,667 |
Premium* |
|
|
CTS Corp |
CTS |
Director |
2023-11-02 |
30,013 |
2018-11-08 |
0 |
Premium* |
|
|
Syneos Health Inc |
SYNH |
Director |
2023-05-25 |
8,356 |
2022-01-18 |
0 |
Premium* |
|
|
First Light Acquisition Group, I... |
FLAG |
Director |
2023-12-21 |
133,301 |
2023-12-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
56 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
• – – |
2019-09-03 |
4 |
AS |
$112.91 |
$2,201,745 |
D/D |
(19,500) |
38,306 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
• – – |
2019-09-20 |
4 |
AS |
$117.00 |
$526,500 |
D/D |
(4,500) |
33,806 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
• – – |
2019-12-06 |
4 |
AS |
$120.00 |
$540,000 |
D/D |
(4,500) |
29,306 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
• – – |
2020-06-05 |
4 |
AS |
$150.00 |
$1,500,000 |
D/D |
(10,000) |
46,646 |
0 |
% |
|
| LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
• – – |
2020-06-16 |
4 |
AS |
$160.00 |
$2,770,000 |
D/D |
(17,000) |
29,646 |
0 |
% |
|
| CTS |
CTS Corp |
Director |
– • – |
2020-03-09 |
4 |
B |
$22.19 |
$19,971 |
D/D |
900 |
9,500 |
2.39 |
% |
|
| CTS |
CTS Corp |
Director |
– • – |
2020-03-10 |
4 |
B |
$23.51 |
$19,984 |
D/D |
850 |
10,350 |
2.39 |
% |
|
| CTS |
CTS Corp |
Director |
– • – |
2020-03-11 |
4 |
B |
$23.45 |
$20,167 |
D/D |
860 |
11,210 |
2.39 |
% |
|
| CTS |
CTS Corp |
Director |
– • – |
2020-03-12 |
4 |
B |
$21.59 |
$18,632 |
D/D |
863 |
12,073 |
2.39 |
% |
|
| CTS |
CTS Corp |
Director |
– • – |
2020-03-13 |
4 |
B |
$22.17 |
$20,840 |
D/D |
940 |
13,013 |
2.39 |
% |
|
| LLY |
Eli Lilly & Co |
SVP& Pres., Emerging Markets |
• – – |
2014-10-01 |
4 |
D |
$64.85 |
$284,302 |
D/D |
(4,384) |
39,112 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP& Pres., Emerging Markets |
• – – |
2014-11-07 |
4 |
D |
$66.96 |
$1,289,248 |
D/D |
(19,254) |
41,160 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP& Pres., Emerging Markets |
• – – |
2015-11-20 |
4 |
D |
$83.72 |
$809,907 |
D/D |
(9,674) |
55,066 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP& Pres., Emerging Markets |
• – – |
2017-02-01 |
4 |
D |
$77.03 |
$240,873 |
D/D |
(3,127) |
60,583 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
• – – |
2018-02-01 |
4 |
D |
$81.45 |
$580,983 |
D/D |
(7,133) |
58,224 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
• – – |
2019-02-01 |
4 |
D |
$119.86 |
$523,069 |
D/D |
(4,364) |
46,582 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
• – – |
2020-02-01 |
4 |
D |
$139.64 |
$1,019,232 |
D/D |
(7,299) |
38,324 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
• – – |
2021-02-01 |
4 |
D |
$207.97 |
$1,557,695 |
D/D |
(7,490) |
27,910 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP& Pres., Emerging MarketsOf |
• – – |
2014-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
22,830 |
|
- |
|
| LLY |
Eli Lilly & Co |
SVP& Pres., Emerging MarketsOf |
• – – |
2014-01-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,957 |
|
- |
|
| LLY |
Eli Lilly & Co |
SVP& Pres., Emerging Markets |
• – – |
2014-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,333 |
43,496 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP& Pres., Emerging Markets |
• – – |
2014-11-07 |
4 |
OE |
$55.65 |
$1,185,456 |
D/D |
21,302 |
60,414 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP& Pres., Emerging Markets |
• – – |
2015-11-20 |
4 |
OE |
$56.18 |
$676,857 |
D/D |
12,048 |
64,740 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP& Pres., Emerging Markets |
• – – |
2017-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,659 |
63,710 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
• – – |
2018-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,993 |
65,357 |
0 |
- |
|
56 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
